A Two-Front War : Targeting Synchronous Metastatic Pancreatic and Renal Cell Carcinomas with the Combination of Gemcitabine and Sunitinib

doi:N/A

submission@lmj.com

FAQs

Lebanese Medical Journal

Home
- Archives
- Articles In-Press
- Instructions of Authors
Submit Article

Cite

APA

Assi, T., Rassy, E. E., Moussa, T. & Kattan, J. (2024). A Two-Front War : Targeting Synchronous Metastatic Pancreatic and Renal Cell Carcinomas with the Combination of Gemcitabine and Sunitinib. Lebanese Medical Journal, 67(1), None-None.

MLA

Assi, Tarek, et al. "A Two-Front War : Targeting Synchronous Metastatic Pancreatic and Renal Cell Carcinomas with the Combination of Gemcitabine and Sunitinib." Lebanese Medical Journal 67.1 (2024): None-None.

Chicago

Assi, Tarek, Elie E. Rassy, Tania Moussa and Joseph Kattan. "A Two-Front War : Targeting Synchronous Metastatic Pancreatic and Renal Cell Carcinomas with the Combination of Gemcitabine and Sunitinib." Lebanese Medical Journal 67, no. 1 (2024): None-None.

Harvard

Assi, T., Rassy, E. E., Moussa, T. and Kattan, J. (2024) 'A Two-Front War : Targeting Synchronous Metastatic Pancreatic and Renal Cell Carcinomas with the Combination of Gemcitabine and Sunitinib' Lebanese Medical Journal 67(1), pp. None-None.

Vancouver

Assi T, Rassy EE, Moussa T, Kattan J. A Two-Front War : Targeting Synchronous Metastatic Pancreatic and Renal Cell Carcinomas with the Combination of Gemcitabine and Sunitinib. Lebanese Medical Journal. 2024 ;67(1):None-None.